Proteogenomics of Colorectal Cancer Liver Metastases: Complementing Precision Oncology with Phenotypic Data

Hotspot testing for activating KRAS mutations is used in precision oncology to select colorectal cancer (CRC) patients who are eligible for anti-EGFR treatment. However, even for KRAS(wildtype) tumors anti-EGFR response rates are <30%, while mutated-KRAS does not entirely rule out response, indic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Blank-Landeshammer, Bernhard, Richard, Vincent R., Mitsa, Georgia, Marques, Maud, LeBlanc, André, Kollipara, Laxmikanth, Feldmann, Ingo, Couetoux du Tertre, Mathilde, Gambaro, Karen, McNamara, Suzan, Spatz, Alan, Zahedi, René P., Sickmann, Albert, Batist, Gerald, Borchers, Christoph H.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6966481/
https://ncbi.nlm.nih.gov/pubmed/31805664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11121907
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados